Current issue
About the Journal
Scientific Council
Editorial Board
Regulatory and archival policy
Code of publishing ethics
Publisher
Information about the processing of personal data in relation to cookies and newsletter subscription
Archive
For Authors
For Reviewers
Contact
Reviewers
Annals reviewers in 2023
Annals reviewers in 2022
Annals reviewers in 2021
Annals reviewers in 2020
Annals reviewers in 2019
Annals reviewers in 2018
Annals reviewers in 2017
Annals reviewers in 2016
Annals reviewers in 2015
Annals reviewers in 2014
Annals reviewers in 2013
Annals reviewers in 2012
Links
Sklep Wydawnictwa SUM
Biblioteka Główna SUM
Śląski Uniwersytet Medyczny w Katowicach
Privacy policy
Accessibility statement
Reviewers
Annals reviewers in 2023
Annals reviewers in 2022
Annals reviewers in 2021
Annals reviewers in 2020
Annals reviewers in 2019
Annals reviewers in 2018
Annals reviewers in 2017
Annals reviewers in 2016
Annals reviewers in 2015
Annals reviewers in 2014
Annals reviewers in 2013
Annals reviewers in 2012
HPV among men – what knowledge we have in this field
1
Students’ Scientific Club at the Department of Environmental Medicine and Epidemiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
2
Department of Environmental Medicine and Epidemiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
Corresponding author
Jakub Fiegler-Rudol
Studenckie Koło Naukowe przy Katedrze i Zakładzie Epidemiologii i Medycyny Środowiskowej, Wydział Nauk Medycznych w Zabrzu, Śląski Uniwersytet Medyczny w Katowicach, ul. Jordana 19, 41-808 Zabrze
Studenckie Koło Naukowe przy Katedrze i Zakładzie Epidemiologii i Medycyny Środowiskowej, Wydział Nauk Medycznych w Zabrzu, Śląski Uniwersytet Medyczny w Katowicach, ul. Jordana 19, 41-808 Zabrze
Ann. Acad. Med. Siles. 2024;2(nr specj.):6-11
KEYWORDS
TOPICS
ABSTRACT
The human papillomavirus (HPV) is a common sexually transmitted DNA virus. The resulting infection may be asymptomatic or manifest itself through benign symptoms such as warts, affecting the genitals and skin. It is a common etiological factor associated with various cancers, most notably cervical cancer. The prevalence of genital HPV in healthy men is high and can be higher than in women in certain populations. The virus is transmitted sexually. Contraceptive methods do not protect against transmission as it can be transmitted through the skin of the scrotum. Rates vary drastically based on factors such as the country of residence, socioeconomic status, ethnicity as well as the screening methods used. Population factors affect HPV vaccine acceptance. The awareness about HPV has improved over the past two decades, with women historically being more informed. However, awareness is still inadequate, especially among certain demographic groups. Despite men currently showing similar awareness levels to women, a significant percentage have not been vaccinated. Not only are men an important vector for infection, but HPV is correlated with several cancerous changes observed among men. Attitudes towards HPV vaccination differ, with some influenced by vaccine hesitancy, which itself is correlated with knowledge. These individuals face higher risks due to lower vaccination rates for HPV.
REFERENCES (41)
1.
Sexually Transmitted Infections (STIs). Centers for Disease Control and Prevention, 2024 [online] https://www.cdc.gov/sti/?CDC_A... [accessed on 17 September 2024].
2.
About Genital HPV Infection. Centers for Disease Control and Prevention, February 6, 2024 [online] https://www.cdc.gov/sti/about/... [accessed on 17 September 2024].
3.
Wierzbicka M., San Giorgi M.R.M., Dikkers F.G. Transmission and clearance of human papillomavirus infection in the oral cavity and its role in oropharyngeal carcinoma – A review. Rev. Med. Virol. 2023; 33(1): e2337, doi: 10.1002/rmv.2337.
4.
Laganà A.S., Chiantera V., Gerli S., Proietti S., Lepore E., Unfer V. et al. Preventing persistence of HPV infection with natural molecules. Pathogens 2023; 12(3): 416, doi: 10.3390/pathogens12030416.
5.
Charde S.H., Warbhe R.A. Human papillomavirus prevention by vaccination: A review article. Cureus 2022; 14(10): e30037, doi: 10.7759/cureus.30037.
6.
Condom Use: An Overview. Centers for Disease Control and Prevention, January 19, 2024 [online] https://www.cdc.gov/condom-use... [accessed on 17 September 2024].
7.
One in three men worldwide are infected with genital human papillomavirus. World Health Organization, 1 September 2023 [online] https://www.who.int/news/item/... [accessed on 27 September 2023].
8.
Burd E.M. Human papillomavirus and cervical cancer. Clin. Microbiol. Rev. 2003; 16(1): 1–17, doi: 10.1128/CMR.16.1.1-17.2003.
9.
Human papillomavirus vaccines – Cervarix, Gardasil, Gardasil 9, Silgard – referral. European Medicines Agency, 2015 [online] https://www.ema.europa.eu/en/m... [accessed on 21 November 2023].
10.
Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Ault K.A., Giuliano A.R. et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005; 6(5): 271–278, doi: 10.1016/S1470-2045(05)70101-7.
11.
HPV and cancer. National Cancer Institute, 2023 [online] https://www.cancer.gov/about-c... [accessed on 27 October 2023].
12.
Anic G.M., Giuliano A.R. Genital HPV infection and related lesions in men. Prev. Med. 2011; 53(Suppl 1): S36–41, doi: 10.1016/j.ypmed.2011.08.002.
13.
McQuillan G., Kruszon-Moran D., Markowitz L.E., Unger E.R., Paulose-Ram R. Prevalence of HPV in adults aged 18–69: United States, 2011–2014. NCHS Data Brief. 2017; 280: 1–8.
14.
Machalek D.A., Chow E.P., Garland S.M., Wigan R., Cornall A.M., Fairley C.K. et al. Human papillomavirus prevalence in unvaccinated heterosexual men after a national female vaccination program. J. Infect. Dis. 2017; 215(2): 202–208, doi: 10.1093/infdis/jiw530.
15.
Ng’ayo M.O., Bukusi E., Rowhani-Rahbar A., Koutsky L.A., Feng Q., Kwena Z.A. et al. Epidemiology of human papillomavirus infection among fishermen along Lake Victoria Shore in the Kisumu District, Kenya. Sex. Transm. Infect. 2008; 84(1): 62–66, doi: 10.1136/sti.2007.027508.
16.
Bruni L., Albero G., Rowley J., Alemany L., Arbyn M., Giuliano A.R. et al. Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis. Lancet Glob. Health 2023; 11(9): e1345–e1362, doi: 10.1016/S2214-109X(23)00305-4.
17.
Kombe Kombe A.J., Li B., Zahid A., Mengist H.M., Bounda G.A., Zhou Y. et al. Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation. Front. Public Health 2021; 8: 552028, doi: 10.3389/fpubh.2020.552028.
18.
Giuliano A.R., Lazcano-Ponce E., Villa L.L., Flores R., Salmeron J., Lee J.H. et al. The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol. Biomarkers Prev. 2008; 17(8): 2036–2043, doi: 10.1158/1055-9965.EPI-08-0151.
19.
Nielson C.M., Flores R., Harris R.B., Abrahamsen M., Papenfuss M.R., Dunne E.F. et al. Human papillomavirus prevalence and type distribution in male anogenital sites and semen. Cancer Epidemiol. Biomarkers Prev. 2007; 16(6): 1107–1114, doi: 10.1158/1055-9965.EPI-06-0997.
20.
Sonawane K., Suk R., Chiao E.Y., Chhatwal J., Qiu P., Wilkin T. et al. Oral human papillomavirus infection: differences in prevalence between sexes and concordance with genital human papillomavirus infection, NHANES 2011 to 2014. Ann. Intern. Med. 2017; 167(10): 714–724, doi: 10.7326/M17-1363.
21.
Van Doornum G.J., Prins M., Juffermans L.H., Hooykaas C., van den Hoek J.A., Coutinho R. et al. Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study. Genitourin. Med. 1994; 70(4): 240–246, doi: 10.1136/sti.70.4.240.
22.
Argyri E., Papaspyridakos S., Tsimplaki E., Michala L., Myriokefalitaki E., Papassideri I. et al. A cross sectional study of HPV type prevalence according to age and cytology. BMC Infect. Dis. 2013; 13: 53, doi: 10.1186/1471-2334-13-53.
23.
Shin H., Jeon S., Cho I., Park H. Factors affecting human papillomavirus vaccination in men: systematic review. JMIR Public Health Surveill. 2022; 8(4): e34070, doi: 10.2196/34070.
24.
Dela Cruz M.R.I., Braun K.L., Tsark J.A.U., Albright C.L., Chen J.J. HPV vaccination prevalence, parental barriers and motivators to vaccinating children in Hawai’i. Ethn. Health 2020; 25(7): 982–994, doi: 10.1080/13557858.2018.1473556.
25.
Kepka D., Ding Q., Hawkins A.J., Warner E.L., Boucher K.M. Factors associated with early adoption of the HPV vaccine in US male adolescents include Hispanic ethnicity and receipt of other vaccines. Prev. Med. Rep. 2016; 4: 98–102, doi: 10.1016/j.pmedr.2016.05.014.
26.
Johnson K.L., Lin M.Y., Cabral H., Kazis L.E., Katz I.T. Variation in human papillomavirus vaccine uptake and acceptability between female and male adolescents and their caregivers. J. Community Health 2017; 42(3): 522–532, doi: 10.1007/s10900-016-0284-5.
27.
Charlton B.M., Reisner S.L., Agénor M., Gordon A.R., Sarda V., Austin S.B. Sexual orientation disparities in human papillomavirus vaccination in a longitudinal cohort of U.S. males and females. LGBT Health 2017; 4(3): 202–209, doi: 10.1089/lgbt.2016.0103.
28.
Cernasev A., Yoby A.G., Hagemann T. Increasing awareness of the human papillomavirus (HPV) vaccine for women 18–45 years of age. Women 2023; 3(3): 365–373, doi: 10.3390/women3030027.
29.
Preston S.M., Darrow W.W. Are men being left behind (or catching up)? Differences in HPV awareness, knowledge, and attitudes between diverse college men and women. Am. J. Mens Health 2019; 13(6): 1557988319883776, doi: 10.1177/1557988319883776.
30.
Yacobi E., Tennant C., Ferrante J., Pal N., Roetzheim R. University students’ knowledge and awareness of HPV. Prev. Med. 1999; 28(6): 535–541, doi: 10.1006/pmed.1999.0486.
31.
Gerend M.A., Magloire Z.F. Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults. J. Adolesc. Health 2008; 42(3): 237–242, doi: 10.1016/j.jadohealth.2007.08.022.
32.
Kellogg C., Shu J., Arroyo A., Dinh N.T., Wade N., Sanchez E. et al. A significant portion of college students are not aware of HPV disease and HPV vaccine recommendations. Hum. Vaccin. Immunother. 2019; 15(7–8): 1760–1766, doi: 10.1080/21645515.2019.1627819.
33.
Dobko K., Frącz G., Glac A., Kuliga K., Musz K., Sejnowska N. et al. Knowledge of women and men about human papillomavirus infection, HPV-related diseases and the available vaccine. J. Educ. Health Sport 2023; 18(1): 89–108, doi: 10.12775/JEHS.2023.18.01.010.
34.
de Fouw M., Stroeken Y., Niwagaba B., Musheshe M., Tusiime J., Sadayo I. et al. Involving men in cervical cancer prevention; a qualitative enquiry into male perspectives on screening and HPV vaccination in Mid-Western Uganda. PLoS One 2023; 18(1): e0280052, doi: 10.1371/journal.pone.0280052.
35.
Barnard M., George P., Perryman M.L., Wolff L.A. Human papillomavirus (HPV) vaccine knowledge, attitudes, and uptake in college students: Implications from the Precaution Adoption Process Model. PLoS One. 2017; 12(8): 1.
36.
Frazer I.H. The HPV vaccine story. ACS Pharmacol. Transl. Sci. 2019; 2(3): 210–212, doi: 10.1021/acsptsci.9b00032.
37.
Brewer N.T., Fazekas K.I. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev. Med. 2007; 45(2–3): 107–114, doi: 10.1016/j.ypmed.2007.05.013.
38.
Otanez S., Torr B.M. Ethnic and racial disparities in HPV vaccination attitudes. J. Immigr. Minor. Health 2018; 20(6): 1476–1482, doi: 10.1007/s10903-017-0685-2.
39.
Newman P.A., Logie C.H., Doukas N., Asakura K. HPV vaccine acceptability among men: a systematic review and meta-analysis. Sex. Transm. Infect. 2013; 89(7): 568–574, doi: 10.1136/sextrans-2012-050980.
40.
Chidobem I., Tian F., Ogbuokiri E., Mgbodile F., Mgbodile C., Jokar T.O. et al. Trends in HPV and HPV vaccine awareness among gay and bisexual males in the U.S. Vaccines (Basel) 2022; 10(4): 604–607, doi: 10.3390/vaccines10040604.
41.
Reiter P.L., McRee A.L., Katz M.L., Paskett E.D. Human papillomavirus vaccination among young adult gay and bisexual men in the United States. Am. J. Public Health 2015; 105(1): 96–102, doi: 10.2105/AJPH.2014.302095.
Share
RELATED ARTICLE
| eISSN: | 1734-025X |
The Medical University of Silesia in Katowice, as the Operator of the annales.sum.edu.pl website, processes personal data collected when visiting the website. The function of obtaining information about Users and their behavior is carried out by voluntarily entered information in forms, saving cookies in end devices, as well as by collecting web server logs, which are in the possession of the website Operator. Data, including cookies, are used to provide services in accordance with the Privacy policy.
You can consent to the processing of data for these purposes, refuse consent or access more detailed information.
You can consent to the processing of data for these purposes, refuse consent or access more detailed information.
